IND Swift Laboratories Equity

What does IND Swift Laboratories do? Ind-Swift Laboratories Ltd. generates revenue through the manufacturing and marketing of pharmaceutical ingredients, including Advanced Intermediates and reference standards for active pharmaceutical ingredients (APIs). The company supplies reference standards and impurities for over 25 APIs under pharmacopoeias such as British Pharmacopoeia (BP) and European Pharmacopoeia (EP), providing full documentation including Certificate of Analysis and MSDS with each shipment. Its research center, covering 40,000 square feet, develops process technology for APIs across various therapeutic categories, supporting both generic and innovative pharmaceutical organizations as API partners. The firm's primary customers are pharmaceutical companies requiring intermediates, formulations, and reference standards for API development and quality control. These organizations include both generic and innovative domain partners who rely on Ind-Swift's impurity portfolio and certified reference materials. The company's product offerings are tailored to meet the needs of clients in the pharmaceutical industry seeking compliant, high-quality raw materials and testing solutions. Ind-Swift's revenue streams are driven by the sale of Advanced Intermediates, reference standards, and impurities for APIs, with a focus on supplying documentation-compliant products. The company's API partnership model ensures consistent demand from clients needing reliable sources of pharmaceutical ingredients and testing materials, particularly for regulatory compliance in global markets. IND Swift Laboratories is one of the most popular companies on Eulerpool.